Our in vitro glioma IHC analysis also confirmed the riskscore positively correlated with IBA1, TMEM119, CD68, CSF1R, and TGFB1 protein expression (Figure 6D,E and Figure S3D–F). The gene discussed is CD68; the disease is central nervous system cancer.